These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2861250)
21. Nicotinic cholinergic receptor in brain detected by binding of alpha-(3 H) bungarotoxin. Eterović VA; Bennett EL Biochim Biophys Acta; 1974 Sep; 362(2):346-55. PubMed ID: 4424687 [No Abstract] [Full Text] [Related]
22. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122 [TBL] [Abstract][Full Text] [Related]
23. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. Araujo DM; Lapchak PA; Collier B; Quirion R J Neurochem; 1988 Jul; 51(1):292-9. PubMed ID: 3379410 [TBL] [Abstract][Full Text] [Related]
24. The action of cholinomimetic and cholinolytic agents, hemicholinium-3 and alpha- and beta-bungarotoxin on the body wall muscle of the earthworm, Lumbricus terrestris. Hassoni AA; Kerkut GA; Walker RJ Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(1):179-92. PubMed ID: 2865060 [TBL] [Abstract][Full Text] [Related]
25. alpha-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Quik M; Chan J; Patrick J Brain Res; 1994 Aug; 655(1-2):161-7. PubMed ID: 7812768 [TBL] [Abstract][Full Text] [Related]
26. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists. Quik M; Geertsen S; Trifaró JM Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287 [TBL] [Abstract][Full Text] [Related]
27. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514 [TBL] [Abstract][Full Text] [Related]
28. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line. Peng JH; Lucero L; Fryer J; Herl J; Leonard SS; Lukas RJ Brain Res; 1999 Apr; 825(1-2):172-9. PubMed ID: 10216184 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors. Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque. Min CK; Owens J; Weiland GA Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439 [TBL] [Abstract][Full Text] [Related]
31. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta. Han ZY; Zoli M; Cardona A; Bourgeois JP; Changeux JP; Le Novère N J Comp Neurol; 2003 Jun; 461(1):49-60. PubMed ID: 12722104 [TBL] [Abstract][Full Text] [Related]
32. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition. Costa LG; Murphy SD J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853 [TBL] [Abstract][Full Text] [Related]
33. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626 [TBL] [Abstract][Full Text] [Related]
34. Phorbol esters and d-tubocurarine up-regulate alpha-bungarotoxin sites in chromaffin cells in culture via distinct mechanisms. Geertsen S; Afar R; Trifaró JM; Quik M Neuroscience; 1990; 34(2):441-50. PubMed ID: 2159130 [TBL] [Abstract][Full Text] [Related]
35. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Marks MJ; Collins AC Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123 [TBL] [Abstract][Full Text] [Related]
36. Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine. Happe HK; Peters JL; Bergman DA; Murrin LC Neuroscience; 1994 Oct; 62(3):929-44. PubMed ID: 7870314 [TBL] [Abstract][Full Text] [Related]
37. Nicotinic cholinergic receptors in brain synaptosomes. Yoshida K; Imura H Brain Res; 1979 Aug; 172(3):453-9. PubMed ID: 476492 [TBL] [Abstract][Full Text] [Related]
38. Regulation of alpha 4 beta 2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Zhang X; Gong ZH; Hellström-Lindahl E; Nordberg A Neuroreport; 1995 Jan; 6(2):313-7. PubMed ID: 7756618 [TBL] [Abstract][Full Text] [Related]